Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;15(12):1181-9.
doi: 10.1038/ni.3006. Epub 2014 Oct 12.

High-dimensional analysis of the murine myeloid cell system

Affiliations

High-dimensional analysis of the murine myeloid cell system

Burkhard Becher et al. Nat Immunol. 2014 Dec.

Abstract

Advances in cell-fate mapping have revealed the complexity in phenotype, ontogeny and tissue distribution of the mammalian myeloid system. To capture this phenotypic diversity, we developed a 38-antibody panel for mass cytometry and used dimensionality reduction with machine learning-aided cluster analysis to build a composite of murine (mouse) myeloid cells in the steady state across lymphoid and nonlymphoid tissues. In addition to identifying all previously described myeloid populations, higher-order analysis allowed objective delineation of otherwise ambiguous subsets, including monocyte-macrophage intermediates and an array of granulocyte variants. Using mice that cannot sense granulocyte macrophage-colony stimulating factor GM-CSF (Csf2rb(-/-)), which have discrete alterations in myeloid development, we confirmed differences in barrier tissue dendritic cells, lung macrophages and eosinophils. The methodology further identified variations in the monocyte and innate lymphoid cell compartment that were unexpected, which confirmed that this approach is a powerful tool for unambiguous and unbiased characterization of the myeloid system.

PubMed Disclaimer

Comment in

References

    1. Immunity. 1995 Mar;2(3):211-22 - PubMed
    1. Immunity. 2011 Sep 23;35(3):323-35 - PubMed
    1. Nat Biotechnol. 2012 Sep;30(9):858-67 - PubMed
    1. J Immunol. 2000 Aug 15;165(4):1965-75 - PubMed
    1. Nat Rev Immunol. 2009 Mar;9(3):162-74 - PubMed

Publication types